Autism spectrum disorder and genetic testing: Parental perceptions and decision-making

Alyson E. Hanish, Marlene Z. Cohen, Lois J Starr

Research output: Contribution to journalArticle

Abstract

Purpose: Advances in genomic technology and research have led to genetic testing being recognized as an essential component of the etiological workup for children with autism spectrum disorder (ASD). Chromosomal microarray analysis (CMA) is a first-tier diagnostic test for patients with ASD, as recommended by the American College of Medical Genetics and other professional societies. An accurate underlying medical diagnosis for ASD has many potential benefits, including appropriate medical management, detailed therapeutic recommendations, and accurate recurrence risk. Genetic testing is relatively complicated, expensive, and, currently, in the majority of the cases, does not provide any organic improvement in the management of symptoms. Design and Methods: We conducted semistructured interviews with 20 parents to explore the decision-making process of genetic testing from the perspectives and experiences of parents of children with ASD. Data were analyzed using qualitative content analysis. Results: Parents had limited knowledge of genetic testing for ASD prior to a genetics clinic visit. The majority of the participants thought genetic testing would be beneficial for their child, their reproductive choices, and potential future generations. Practice Implications: Various stakeholders (geneticists, primary care providers, nurses, and families) would benefit from future establishment of educational strategies to inform parental decision-making regarding genetic testing for children with ASD.

Original languageEnglish (US)
Article numbere12211
JournalJournal for Specialists in Pediatric Nursing
Volume23
Issue number2
DOIs
StatePublished - Apr 2018

Fingerprint

Genetic Testing
Decision Making
Parents
Social Responsibility
Microarray Analysis
Ambulatory Care
Routine Diagnostic Tests
Autism Spectrum Disorder
Primary Health Care
Nurses
Interviews
Technology
Recurrence
Research

Keywords

  • autism spectrum disorder
  • chromosomal microarray
  • decision-making
  • education
  • genetic testing

ASJC Scopus subject areas

  • Pediatrics

Cite this

Autism spectrum disorder and genetic testing : Parental perceptions and decision-making. / Hanish, Alyson E.; Cohen, Marlene Z.; Starr, Lois J.

In: Journal for Specialists in Pediatric Nursing, Vol. 23, No. 2, e12211, 04.2018.

Research output: Contribution to journalArticle

@article{05e1b65ff2054099957a973a534dc9c7,
title = "Autism spectrum disorder and genetic testing: Parental perceptions and decision-making",
abstract = "Purpose: Advances in genomic technology and research have led to genetic testing being recognized as an essential component of the etiological workup for children with autism spectrum disorder (ASD). Chromosomal microarray analysis (CMA) is a first-tier diagnostic test for patients with ASD, as recommended by the American College of Medical Genetics and other professional societies. An accurate underlying medical diagnosis for ASD has many potential benefits, including appropriate medical management, detailed therapeutic recommendations, and accurate recurrence risk. Genetic testing is relatively complicated, expensive, and, currently, in the majority of the cases, does not provide any organic improvement in the management of symptoms. Design and Methods: We conducted semistructured interviews with 20 parents to explore the decision-making process of genetic testing from the perspectives and experiences of parents of children with ASD. Data were analyzed using qualitative content analysis. Results: Parents had limited knowledge of genetic testing for ASD prior to a genetics clinic visit. The majority of the participants thought genetic testing would be beneficial for their child, their reproductive choices, and potential future generations. Practice Implications: Various stakeholders (geneticists, primary care providers, nurses, and families) would benefit from future establishment of educational strategies to inform parental decision-making regarding genetic testing for children with ASD.",
keywords = "autism spectrum disorder, chromosomal microarray, decision-making, education, genetic testing",
author = "Hanish, {Alyson E.} and Cohen, {Marlene Z.} and Starr, {Lois J}",
year = "2018",
month = "4",
doi = "10.1111/jspn.12211",
language = "English (US)",
volume = "23",
journal = "Journal for Specialists in Pediatric Nursing",
issn = "1539-0136",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Autism spectrum disorder and genetic testing

T2 - Parental perceptions and decision-making

AU - Hanish, Alyson E.

AU - Cohen, Marlene Z.

AU - Starr, Lois J

PY - 2018/4

Y1 - 2018/4

N2 - Purpose: Advances in genomic technology and research have led to genetic testing being recognized as an essential component of the etiological workup for children with autism spectrum disorder (ASD). Chromosomal microarray analysis (CMA) is a first-tier diagnostic test for patients with ASD, as recommended by the American College of Medical Genetics and other professional societies. An accurate underlying medical diagnosis for ASD has many potential benefits, including appropriate medical management, detailed therapeutic recommendations, and accurate recurrence risk. Genetic testing is relatively complicated, expensive, and, currently, in the majority of the cases, does not provide any organic improvement in the management of symptoms. Design and Methods: We conducted semistructured interviews with 20 parents to explore the decision-making process of genetic testing from the perspectives and experiences of parents of children with ASD. Data were analyzed using qualitative content analysis. Results: Parents had limited knowledge of genetic testing for ASD prior to a genetics clinic visit. The majority of the participants thought genetic testing would be beneficial for their child, their reproductive choices, and potential future generations. Practice Implications: Various stakeholders (geneticists, primary care providers, nurses, and families) would benefit from future establishment of educational strategies to inform parental decision-making regarding genetic testing for children with ASD.

AB - Purpose: Advances in genomic technology and research have led to genetic testing being recognized as an essential component of the etiological workup for children with autism spectrum disorder (ASD). Chromosomal microarray analysis (CMA) is a first-tier diagnostic test for patients with ASD, as recommended by the American College of Medical Genetics and other professional societies. An accurate underlying medical diagnosis for ASD has many potential benefits, including appropriate medical management, detailed therapeutic recommendations, and accurate recurrence risk. Genetic testing is relatively complicated, expensive, and, currently, in the majority of the cases, does not provide any organic improvement in the management of symptoms. Design and Methods: We conducted semistructured interviews with 20 parents to explore the decision-making process of genetic testing from the perspectives and experiences of parents of children with ASD. Data were analyzed using qualitative content analysis. Results: Parents had limited knowledge of genetic testing for ASD prior to a genetics clinic visit. The majority of the participants thought genetic testing would be beneficial for their child, their reproductive choices, and potential future generations. Practice Implications: Various stakeholders (geneticists, primary care providers, nurses, and families) would benefit from future establishment of educational strategies to inform parental decision-making regarding genetic testing for children with ASD.

KW - autism spectrum disorder

KW - chromosomal microarray

KW - decision-making

KW - education

KW - genetic testing

UR - http://www.scopus.com/inward/record.url?scp=85045406715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045406715&partnerID=8YFLogxK

U2 - 10.1111/jspn.12211

DO - 10.1111/jspn.12211

M3 - Article

C2 - 29473279

AN - SCOPUS:85045406715

VL - 23

JO - Journal for Specialists in Pediatric Nursing

JF - Journal for Specialists in Pediatric Nursing

SN - 1539-0136

IS - 2

M1 - e12211

ER -